Literature DB >> 9208250

Inhibition of enteropathogenic Escherichia coli adhesion to HEp-2 cells by colostrum and milk from mothers delivering low-birth-weight neonates.

M T Delneri1, S B Carbonare, M L Silva, P Palmeira, M M Carneiro-Sampaio.   

Abstract

UNLABELLED: Breast milk samples from three groups of Brazilian women were evaluated for their inhibitory effect on enteropathogenic Escherichia coli (EPEC) adhesion to HEp-2 cells: G1, mothers delivering preterm babies of appropriate birth weight (n = 12); G2, mothers delivering term babies of low birth weight (n = 11); G3, the control group, mothers delivering term babies of appropriate birth weight (n = 39). Colostrum samples were obtained at 48-72 h and milk samples on the 7th, 30th and 60th days after delivery. All samples showed strong inhibitory activity (66%-100%), without significant differences among the three groups and four periods. Total IgA and anti-EPEC IgA concentrations were significantly higher in colostrum than in milk samples in the three groups studied. The levels of colostral IgA and anti-EPEC IgA observed in G1 and G2 were significantly higher compared to the control group. Western blotting assays showed that individual samples as well as pools of colostrum or milk samples contain IgA antibodies to many EPEC outer membrane proteins. A 94 kDa band with molecular weight consistent with the EPEC adhesin named intimin; was recognized by all samples analysed. Bands of different molecular weight were also recognized by some samples of colostrum and milk, such as a band of approximately 18.4 kDa, with molecular weight equivalent to bundle-forming pilus subunits.
CONCLUSION: Our results suggest that colostrum and milk from mothers of premature and small-for-date term neonates are as effective in protecting the newborn against EPEC infections as those from mothers of term babies of appropriate birth weight.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9208250     DOI: 10.1007/s004310050646

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  7 in total

1.  Effect of domperidone on milk production in mothers of premature newborns: a randomized, double-blind, placebo-controlled trial.

Authors:  O P da Silva; D C Knoppert; M M Angelini; P A Forret
Journal:  CMAJ       Date:  2001-01-09       Impact factor: 8.262

Review 2.  Exploitation of host cells by enteropathogenic Escherichia coli.

Authors:  B A Vallance; B B Finlay
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

Review 3.  Does human milk reduce infection rates in preterm infants? A systematic review.

Authors:  A de Silva; P W Jones; S A Spencer
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2004-11       Impact factor: 5.747

4.  Lactoferrin impairs type III secretory system function in enteropathogenic Escherichia coli.

Authors:  Theresa J Ochoa; Marita Noguera-Obenza; Frank Ebel; Carlos A Guzman; Henry F Gomez; Thomas G Cleary
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

5.  Colostrum from healthy Brazilian women inhibits adhesion and contains IgA antibodies reactive with Shiga toxin-producing Escherichia coli.

Authors:  Patricia Palmeira; Solange Barros Carbonare; José Araujo Amaral; Milene Tino-De-Franco; Magda Maria Sales Carneiro-Sampaio
Journal:  Eur J Pediatr       Date:  2004-11-10       Impact factor: 3.183

6.  Study protocol: a double blind placebo controlled trial examining the effect of domperidone on the composition of breast milk [NCT00308334].

Authors:  Marsha L Campbell-Yeo; Alexander C Allen; K S Joseph; Joyce M Ledwidge; Victoria M Allen; Kent C Dooley
Journal:  BMC Pregnancy Childbirth       Date:  2006-05-23       Impact factor: 3.007

7.  Human milk secretory antibodies against attaching and effacing Escherichia coli antigens.

Authors:  Marita Noguera-Obenza; Theresa J Ochoa; Henry F Gomez; M Lourdes Guerrero; Irene Herrera-Insua; Ardythe L Morrow; Guillermo Ruiz-Palacios; Larry K Pickering; Carlos A Guzman; Thomas G Cleary
Journal:  Emerg Infect Dis       Date:  2003-05       Impact factor: 6.883

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.